Haemonetics Corporation (HAE)

Import this data to Google Sheets with:

=jivedata("HAE","financials")

Full statements spill as a table. For one cell: =jivedata("HAE","Revenue") or =jivedata("HAE","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

Haemonetics Corporation

HAE • CIK 0000313143

(in thousands, except per share data)	FY 2024	FY 2025	FY 2026	TTM
Revenue from Contract with Customer, Including Assessed Tax	$1,309,055	$1,360,824	$1,334,027	$1,352,013
Cost of Goods and Services Sold	$617,507	$611,866	$546,441	$553,868
Gross Profit	$691,548	$748,958	$787,586	$798,145
Operating Income (Loss)	$164,883	$221,817	$156,734	$160,320
Other Nonoperating Income (Expense)	$-13,018	$-9,746	$-28,704	$-29,885
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	$151,865	$212,071	$128,030	$130,435
Income Tax Expense (Benefit)	$34,307	$44,392	$30,722	$34,148
Net Income (Loss) Attributable to Parent	$117,558	$167,679	$97,308	$96,287
Research and Development Expense	$54,435	$62,722	$59,766	$59,705
Selling, General and Administrative Expense	$431,780	$436,789	$442,421	$450,643
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability	$0	$-23,022	$-1,879	$-1,879
Impairment of Intangible Assets, Finite-lived	—	—	$86,546	$86,546
Operating Expenses	$526,665	$527,141	$630,852	$637,825
Weighted Average Number of Shares Outstanding, Basic	50,706,000	50,330,000	47,179,000	44,429,000
Weighted Average Number of Shares Outstanding, Diluted	51,397,000	50,730,000	47,354,000	44,705,000
Weighted Average Number Diluted Shares Outstanding Adjustment	691,000	400,000	175,000	276,000
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	600,000	800,000	936,000,000	935,932,578
Stock Repurchased During Period, Shares	—	3,031,000	—	3,031,000

(in thousands, except per share data)	FY 2024	FY 2025	FY 2026	TTM
Cash and Cash Equivalents, at Carrying Value	$178,800	$306,763	$245,440	$223,384
Accounts Receivable, after Allowance for Credit Loss, Current	$206,562	$202,657	$216,855	$216,071
Property, Plant and Equipment, Net	$311,362	$284,052	$305,761	$303,778
Inventory, Net	$317,202	$365,141	$306,370	$306,739
Intangible Assets, Net (Excluding Goodwill)	$406,117	$455,743	$447,655	$434,512
Prepaid Expense and Other Assets, Current	$66,339	$60,414	$66,214	$64,638
Goodwill	$565,082	$604,269	$656,368	$656,884
Assets, Current	$768,903	$934,975	$834,879	$810,832
Deferred Income Tax Assets, Net	$7,739	$7,803	$9,521	$9,434
Other Assets, Noncurrent	$136,388	$164,106	$141,741	$149,960
Assets	$2,195,591	$2,450,948	$2,395,925	$2,365,400
Long-term Debt, Excluding Current Maturities	$797,564	$921,230	$1,219,565	$1,169,202
Deferred Income Tax Liabilities, Net	$62,644	$62,575	$38,048	$38,691
Other Liabilities, Noncurrent	$75,041	$68,194	$59,393	$57,171
Long-term Debt, Current Maturities	$10,229	$303,558	$5,015	$4,956
Accounts Payable, Current	$73,358	$66,999	$51,056	$56,338
Employee-related Liabilities, Current	$80,708	$59,423	$68,191	$38,145
Other Liabilities, Current	$136,088	$148,133	$158,337	$163,796
Liabilities, Current	$300,383	$578,113	$282,599	$263,235
Common Stock, Value, Issued	$508	$482	$453	$455
Additional Paid in Capital, Common Stock	$634,627	$523,264	$554,137	$566,759
Retained Earnings (Accumulated Deficit)	$360,456	$352,174	$279,344	$311,516
Accumulated Other Comprehensive Income (Loss), Net of Tax	$-35,632	$-55,084	$-37,614	$-41,629
Stockholders' Equity Attributable to Parent	$959,959	$820,836	$796,320	$837,101
Accounts Receivable, Allowance for Credit Loss, Current	$5,695	$6,300	$3,693	$3,618
Finite-Lived Intangible Assets, Accumulated Amortization	$455,213	$316,313	$363,763	$374,828
Common Stock, Shares Authorized	150,000,000	150,000,000	150,000,000	150,000,000
Common Stock, Shares, Issued	50,787,859	48,215,899	45,252,667	45,471,313
Operating Lease, Right-of-Use Asset	$55,268	$47,492	$39,619	$39,619
Operating Lease, Liability, Current	$8,133	$8,107	$9,243	$9,243
Operating Lease, Liability, Noncurrent	$57,958	$50,454	$40,898	$40,898

(in thousands, except per share data)	FY 2024	FY 2025	FY 2026	TTM
Net Income (Loss) Attributable to Parent	$117,558	$167,679	$97,308	$96,287
Net Cash Provided by (Used in) Operating Activities	$181,751	$181,725	$293,221	$328,149
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$-3,185	$-685	$3,463	$-1,336
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	$-105,666	$127,963	$-61,323	$-69,514
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$178,800	$306,763	$245,440	$175,926
Depreciation, Depletion and Amortization, Nonproduction	$97,215	$115,586	$111,717	$110,070
Payments to Acquire Property, Plant, and Equipment	$66,296	$39,278	$32,780	$36,932
Proceeds from Divestiture of Businesses	$1,500	$43,291	$0	$0
Share-based Payment Arrangement, Noncash Expense	$28,332	$29,636	$33,827	$33,826
Proceeds from Sale of Property, Plant, and Equipment	$1,810	$23,253	$1,375	$1,315
Asset Impairment Charges	$10,419	$2,391	$86,546	$86,546
Gain (Loss) on Repurchase of Debt Instrument	—	$12,600	$0	$0
Payments to Acquire Businesses, Net of Cash Acquired	$243,852	$150,906	$60,180	$60,180
Gain (Loss) on Disposition of Property Plant Equipment	—	$15,698	$714	$714
Payments to Acquire Other Investments	$15,551	$17,143	$36,071	$26,988
Net Cash Provided by (Used in) Investing Activities	$-322,389	$-161,895	$-179,547	$-168,781
Deferred Other Tax Expense (Benefit)	$-11,039	$-5,219	$-26,471	$-26,471
Other Operating Activities, Cash Flow Statement	$133	$9,978	$10,726	$11,139
Proceeds from Convertible Debt	—	$700,000	$0	$0
Repayments of Convertible Debt	—	—	$300,000	$300,000
Proceeds from Issuance of Secured Debt	$0	$250,000	$0	$0
Repayments of Other Long-term Debt	—	—	$6,250	$6,250
Proceeds from Long-term Lines of Credit	$110,000	$0	$300,000	$300,000
Repayments of Long-term Lines of Credit	$60,000	$50,000	$0	$50,000
Payments of Debt Issuance Costs	$0	$23,135	$0	$0
Employee Stock Ownership Plan (ESOP), Cash Contributions to ESOP	$5,604	$8,333	$7,893	$7,540
Payment, Tax Withholding, Share-based Payment Arrangement	$5,885	$10,243	$5,001	$3,720
Payments for Repurchase of Common Stock	$0	$225,000	$175,000	$175,000
Proceeds from (Payments for) Other Financing Activities	$-73	$-249	$-102	$-80
Net Cash Provided by (Used in) Financing Activities	$38,157	$108,818	$-178,460	$-227,546
Interest Paid, Excluding Capitalized Interest, Operating Activities	$20,901	$16,534	$17,465	$17,465
Income Taxes Paid	$52,706	$49,293	$60,665	$60,665
Increase (Decrease) in Accounts Receivable	$24,193	$-6,956	$14,881	$18,141
Increase (Decrease) in Inventories	$60,061	$64,704	$-47,361	$-43,061
Increase (Decrease) in Prepaid Taxes	$983	$-226	$4,534	$1,779
Increase (Decrease) in Other Operating Assets and Liabilities, Net	$34,046	$25,232	$35,028	$30,026
Increase (Decrease) in Accounts Payable and Accrued Liabilities	$44,582	$-19,208	$-16,571	$18,710

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("HAE","financials")

Full statements spill as a table. For one cell: =jivedata("HAE","Revenue") or =jivedata("HAE","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.